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A B S T R A C T A series of monoclonal antibodies to T cell surface antigens were used to characterize peripheral lymphoid populations from patients with a variety of immunodeficiency diseases. Several disorders of T cell differentiation were observed to occur in severe combined immunodeficiency. One 
INTRODUCTION
The human immune system, like the murine system, consists of discrete subsets of T lymphocytes which are critical for immune homeostasis (1) (2) . Numerous studies have now demonstrated that it is the balance between effector and regulatory subsets of cells that actually governs the outcome of an immunologic response after antigen triggering. The T inducer/ helper subset facilitates the activation of other cells, including T lymphocytes, B lymphocytes, macrophages, and hematopoietic stem cells (1, (3) (4) (5) (6) . This inductive influence is regulated by the presence of suppressor T lymphocytes, which function to either inactivate the inducer population, or, alternatively, the effector population (6) (7) .
Prior studies have indicated that during intrathymic differentiation and maturation, T cells diverge into functionally distinct subpopulations of cells programmed for their respective inducer/helper and cytotoxic/ suppressor functions (8) . In man, the earliest cells within the thymus bear antigens shared by some bone marrow cells but lacking on mature T lymphocytes. This population (stage I thymocytes) accounts for -10% of the total thymic population and is reactive with two monoclonal antibodies, anti-T9 and anti-T10. With maturation, thymocytes lose T9, retain T10, and acquire a thymocyte-distinct antigen, T6, analogous to the TL antigen in the mouse. Concurrently, these cells express antigens defined by anti-T4 and anti-T5/8. Thus, the T4+, T5/8+, T6+, T10+ thymic population (stage II common thymocytes) accounts for 70-80% of the total. Stage I and II thymocytes are immunologically incompetent. With further maturation, thymocytes lose the T6 antigen, acquire T3, and segregate into distinct T4+ and T5/8+ subsets (stage III thymocytes). Immunologic competence is partially acquired at this stage, but not fully developed until the thymic population is exported, at which time the T10 antigen is lost (9) . The mature circulating T3+, T4+ population and T3+, T5/8+ population are reciprocal subsets of cells and account for 55-65% and 30% of the T cell population, respectively (1). These subsets, in addition to their effector fuinction, exert profound regulatory effects and control both the type and intensity of the cellular immune response. Thus, only the T4+ T cell-induced cytotoxic T killer cells (3), facilitated B cell proliferation, differentiation, and immunoglobulin production (4), and generated soluble helper factors (5) . In contrast, the T5/8+ population became the cytotoxic/effector cell in cell-mediated lympholysis (7), was inducible by concanavalin A to suppress T cell responses (7), and suppressed B cell immunoglobulin production (6) .
Many investigators have reported on aberrations of T cell subsets in immunodeficiency diseases (10) (11) (12) . In the present study, we have examined the differentiation of populations of T lymphocytes in a group of patients with acquired and congenital immunodeficiencies using monoclonal antibodies to mark stages of T cell maturation and to discriminate functionally distinct subsets. Our results support the notion that immunologic incompetence can result from two types of disorders of T cell development. Firstly, there exist disorders associated with release of immature thymocytes into the circulation. On the other hand, immunoincompetence may also result from disorders in which there is either a marked reduction or imbalance in mature T lymphocytes with associated abnormalities in inducer/suppressor cell ratios and function.
METHODS
Patient population. The diagnosis of severe combined immunodeficiency (SCID),' thymic aplasia (DiGeorge syndrome), acquired and X-linked forms of agammaglobulinemia, and IgA deficiency were defined by previously reported criteria (13) . All patients with SCID were adenosine deaminase positive (ADA+). Normal control blood was obtained from healthy individuals undergoing other routine laboratory procedures. No patients were acutely ill or receiving steroid therapy at the time of study.
Mononuclear cell preparation. Mononuclear cells were prepared by Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. Pharmacia, Inc., Piscataway, N. J.) density centrifugation as previously described (9) .
Monoclonal antibodies. A series of monoclonal antibodies was used to define cell surface antigens on human lymphocytes of T lineage. Their production and characterization has been described in detail previously. In brief, anti-T3 was found to be reactive with all peripheral T cells and a 'Abbreviations used in this paper: MLC, mixed lymphocyte culture; SCID, severe combined immunodeficiency. fraction of mature thymocytes (14) . In contrast, anti-T4 and anti-T5/8 reacted with subpopulations of T cells representing 60 and 20-30% of peripheral T cell populations, respectively (3, (7) (8) . The former population defined the human inducer subset, whereas the latter two antibodies defined the cytotoxic/suppressor subset. Anti-T6 defined a thymus specific antigen expressed on 70% of thymocytes and lacking on peripheral lymphocytes of T or non-T lineage (8) . Anti-T9 reacted with an antigen expressed on 10% of thymocytes, but not on resting normal T cells or non-T cells in lymphoid organs. The anti-T1O monoclonal antibody was reactive with .95% of thymocytes, s20% of bone marrow cells, and -<10% of peripheral T cells (8) . Finally, the anti-Ia monoclonal antibody defined a bimolecular glycoprotein antigen complex of 29,000-and 34,000-dalton subunits and was reactive with resting B cells and a fraction of monocytes, but unreactive with resting T cells. This antigen was found to be expressed, moreover, on T cells after activation (14) .
Analysis of lymphocyte populations in patients with immunodeficiency. After separation by density centrifugation, 1-2 x 106 lymphocytes were incubated at 4°C for 30 min in a 1:250 dilution of one or another monoclonal antibody and then washed twice. The cells were subsequently reacted with a 1:40 dilution of goat anti-mouse IgG (G/M FITC) (Meloy Laboratories, Springfield, Va.) or with mouse IgG subclass specific goat antibodies for 30 min, centrifuged, washed three times, and analyzed on a FACS (FACS-I) (Becton-Dickinson, Mountain View, Calif.), Zeiss (Carl Zeiss, Inc., New York) or Leitz (E. Leitz, Inc., Rockleigh, N. J.) immunofluorescent microscope, or both, as previously described (3) (4) 15 (16) . Peripheral blood lymphocytes were analyzed from five of these patients. As shown in Further evidence for the distinctions between SCID patients 1-3 and patients 4 and 5 was a functional observation that the latters' T cells proliferated to alloantigens in MLC, whereas the former's did not (Table I) . However, lymphocytes from all patients lacked proliferative responses to any dose of phytohemagglutinin tested or the specific antigens, tetanus toxoid or diptheria toxoid under optimal culture concentrations (10 ,ug/ml) and despite prior sensitization.
DiGeorge syndrome. Congenital thymic aplasia (DiGeorge syndrome) results from failure of embryogenesis of the entodermal derivatives of the third and fourth pharyngeal pouches (17, 18) . The accompanying T cell defect is associated with susceptibility to viral, fungal, and bacterial infections on the one hand, and an increased incidence of autoimmunity in later years on the other (19 (Table III) . One individual, patient 13, not only had a marked increase in the T5 population but these Table IV shows the results of T cell subset analysis of patients with X-linked agammaglobulinemia who lack surface immunoglobulin positive B cells. The majority of patients with this disorder did not possess a low ratio of inducer/suppressor cells (7 of 11). However, only 3 of 11 patients had a normal ratio; 4 of 11 were found to have a relative increase in their inducer/ suppressor ratio (patients 3, 4, 6, and 7), whereas others had a relative decrease (patients 1, 2, 10, and 11). That these abnormalities of T cell subsets are not accompanying findings in all immunodeficiency state is clear from analysis of T cell subsets in patients with selective IgA deficiency. Individuals with this syndrome had no abnormalities in T cell subsets (Table V) . The observation that three major phenotypic forms of SCID appear to exist is consistent with a variety of functional data implying heterogeneity in this disease category (16) . Thus, one group of SCID patients with circulating stage III thymocytes mounted a normal proliferative response to alloantigens and had relatively normal immunoglobulin levels (Table I , unpublished data). Since it was previously shown that the capacity to proliferate to alloantigens in MLC was developed at the time of acquisition of mature T cell antigens (i.e., T3), these results were not unexpected (9) . In contrast to those individuals, SCID patients with T10 or T9 and T10+ lymphocytes were immunoincompetent and this would appear to correlate with the relative immaturity of this lymphoid population. In these individuals, <5% of their mononuclear population rosetted with sheep erythrocyte (data not shown). In addition, it is of note that one group of SCID patients has been thought to have a "bare lymphocyte syndrome" in which HLA antigens are lacking from circulating lymphocytes (20) . Since HLA related antigens have been shown to be acquired during intrathymic ontogeny, it is likely that this syndrome is associated with the SCID patients who have circulating stage I thymocytes (21) .
In the DiGeorge syndrome, the presence of mature T cells that have diverged into T4+ inducer and the reciprocal T8+ suppressor/cytotoxic cells, is consistent with the view that these patients have a small thymic rudiment (22) . The deficiency of T8+ cells may correlate with the relative inadequacy of the thymic microenvironment and the observation in the murine systems that suppressor populations are short-lived and require rapid renewal from the thymus gland.
Although most cases of agammaglobulinemia result from B cell abnormalities, prior studies provided clear evidence for a multitude of other etiologies for lateonset agammaglobulinemia in individuals possessing circulating B cells (23) (24) (25) . In this regard, in vitro studies have indicated that differentiation of B cells to immunoglobulin secreting plasma cells is regulated by T cells. Specifically, the T4+ population enhances immunoglobulin production whereas the T5/T8+ subset can suppress immunoglobulin secretion by B cells in the presence of T4+ inducer T cells (6) . Perhaps more importantly, the degree of suppression is directly related to the ratio of T4+ and T5/8+ cells. Thus, at a physiologic ratio of 2:1, no suppression is observed, while at lower ratios, (i.e., 1:1, 1:2, 1:5), moderate to marked suppression is seen (6) . These in vitro results and our present findings suggest that a large number of patients with this disease may have acquired agammaglobulinemia on the basis of an abnormally low ratio of inducer/suppressor T lymphocytes.
One individual (case 13) was found to have an elevated number of suppressor cells expressing the Ia antigen, indicating in vivo activation (14) . A similar activated suppressor population has been seen in patients with acute infectious mononucleosis (26) . Thus, viral infection would appear to be capable of activating selectively a suppressor population of cells. This is of interest since acquired agammaglobulinemia has been seen to follow a variety of viral infections including infectious mononucleosis (27) The absence of a predominant T cell subset defect in patients with X-linked agammaglobulinemia who lacked circulating surface immunoglobulin bearing cells is consistent with the view that this disease is due to an aberrant differentiation along cells of B, rather than T lineage. However, the observation that patients with both decreased as well as increased inducer/suppressor ratios are frequently detected, suggests that the disease is heterogeneous. In this regard, the multiple infections often contracted by these patients may alter their T cell population. Alternatively, the T cell subset abnormalities may be secondary to the B cell defects themselves. In either case, such combined T and B cell abnormalities may serve to propagate the immunodeficiency state or to thwart their repair with healthy donor cells (28) . The use of monoclonal antibodies to precisely define the abnormalities of lymphoid cells will undoubtedly help to unravel this complexity. It is also likely in the future that even more sophisticated probes will be able to define defects in class specific helper or suppressor T cells resulting in selective isotype deficiencies.
